Regeneron Pharmaceuticals, Inc. 13D and 13G filings for Decibel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-27 4:05 pm Sale | 2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 100 100.000% | -2,097,214 (-100.00%) | Filing |
| 2023-08-18 5:16 pm Unchanged | 2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.300% | 0 (Unchanged) | Filing |
| 2022-02-11 4:05 pm Purchase | 2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.420% | 2,097,314 (New Position) | Filing |